BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11581419)

  • 1. Positively charged termini of the L2 minor capsid protein are necessary for papillomavirus infection.
    Roden RB; Day PM; Bronzo BK; Yutzy WH; Yang Y; Lowy DR; Schiller JT
    J Virol; 2001 Nov; 75(21):10493-7. PubMed ID: 11581419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidation.
    Okun MM; Day PM; Greenstone HL; Booy FP; Lowy DR; Schiller JT; Roden RB
    J Virol; 2001 May; 75(9):4332-42. PubMed ID: 11287582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains.
    Day PM; Roden RB; Lowy DR; Schiller JT
    J Virol; 1998 Jan; 72(1):142-50. PubMed ID: 9420209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence close to the N-terminus of L2 protein is displayed on the surface of bovine papillomavirus type 1 virions.
    Liu WJ; Gissmann L; Sun XY; Kanjanahaluethai A; Müller M; Doorbar J; Zhou J
    Virology; 1997 Jan; 227(2):474-83. PubMed ID: 9018146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The positively charged termini of L2 minor capsid protein required for bovine papillomavirus infection function separately in nuclear import and DNA binding.
    Fay A; Yutzy WH; Roden RB; Moroianu J
    J Virol; 2004 Dec; 78(24):13447-54. PubMed ID: 15564455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboxyl terminus of bovine papillomavirus type-1 L1 protein is not required for capsid formation.
    Paintsil J; Müller M; Picken M; Gissmann L; Zhou J
    Virology; 1996 Sep; 223(1):238-44. PubMed ID: 8806558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.
    Roden RB; Greenstone HL; Kirnbauer R; Booy FP; Jessie J; Lowy DR; Schiller JT
    J Virol; 1996 Sep; 70(9):5875-83. PubMed ID: 8709207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm.
    Kawana Y; Kawana K; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
    J Virol; 2001 Mar; 75(5):2331-6. PubMed ID: 11160736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell surface-binding motifs of L2 that facilitate papillomavirus infection.
    Yang R; Day PM; Yutzy WH; Lin KY; Hung CF; Roden RB
    J Virol; 2003 Mar; 77(6):3531-41. PubMed ID: 12610128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression.
    Day PM; Baker CC; Lowy DR; Schiller JT
    Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14252-7. PubMed ID: 15383670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiency of delivery of DNA to cells by bovine papillomavirus type-1 L1/L2 pseudovirions.
    Liu Y; Frazer IH; Liu WJ; Liu XS; McMillan N; Zhao KN
    Appl Microbiol Biotechnol; 2001 Jul; 56(1-2):150-6. PubMed ID: 11499923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA binding of L1 is required for human papillomavirus morphogenesis in vivo.
    Schäfer F; Florin L; Sapp M
    Virology; 2002 Mar; 295(1):172-81. PubMed ID: 12033775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA packaging by L1 and L2 capsid proteins of bovine papillomavirus type 1.
    Zhao KN; Sun XY; Frazer IH; Zhou J
    Virology; 1998 Apr; 243(2):482-91. PubMed ID: 9568045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of tSNARE syntaxin 18 with the papillomavirus minor capsid protein mediates infection.
    Bossis I; Roden RB; Gambhira R; Yang R; Tagaya M; Howley PM; Meneses PI
    J Virol; 2005 Jun; 79(11):6723-31. PubMed ID: 15890910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization.
    Kirnbauer R; Chandrachud LM; O'Neil BW; Wagner ER; Grindlay GJ; Armstrong A; McGarvie GM; Schiller JT; Lowy DR; Campo MS
    Virology; 1996 May; 219(1):37-44. PubMed ID: 8623552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maturation of papillomavirus capsids.
    Buck CB; Thompson CD; Pang YY; Lowy DR; Schiller JT
    J Virol; 2005 Mar; 79(5):2839-46. PubMed ID: 15709003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assembly and translocation of papillomavirus capsid proteins.
    Florin L; Sapp C; Streeck RE; Sapp M
    J Virol; 2002 Oct; 76(19):10009-14. PubMed ID: 12208977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reorganization of nuclear domain 10 induced by papillomavirus capsid protein l2.
    Florin L; Schäfer F; Sotlar K; Streeck RE; Sapp M
    Virology; 2002 Mar; 295(1):97-107. PubMed ID: 12033769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequences required for the nuclear targeting and accumulation of human papillomavirus type 6B L2 protein.
    Sun XY; Frazer I; Müller M; Gissmann L; Zhou J
    Virology; 1995 Nov; 213(2):321-7. PubMed ID: 7491757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organization of the major and minor capsid proteins in human papillomavirus type 33 virus-like particles.
    Sapp M; Volpers C; Müller M; Streeck RE
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2407-12. PubMed ID: 7561785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.